Germany · Question · Schriftliche Frage
17/10606
Success of the disease management programs (DMP) according to the Risk Structure Compensation Ordinance; Discontinuation of bonus measures for DMP patients by the health insurance companies
Introduced
7 September 2012
Last action
—
Status
Beantwortet
Sponsors
—
Subjects
Discovery layer
Source updated
26 July 2022
Summary
Original text of the question(s):<br /> <br /> What current knowledge does the federal government have about the participation and success of the disease management programs (DMP) according to the Risk Structure Compensation Ordinance (RSAV), and how does the federal government assess the health insurance companies' bonus measures for DMP patients, which have now largely been discontinued, for their participation in the DMP?
Machine translation from German. The official text remains authoritative.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.